MetLife, Inc. (NYSE:MET) Shares Purchased by PGGM Investments
by Doug Wharley · The Cerbat GemPGGM Investments grew its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 11.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 88,265 shares of the financial services provider’s stock after acquiring an additional 9,270 shares during the quarter. PGGM Investments’ holdings in MetLife were worth $7,227,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of the company. Bank of New York Mellon Corp increased its position in MetLife by 109.2% during the 4th quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider’s stock worth $722,727,000 after purchasing an additional 4,606,748 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in MetLife by 1.5% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider’s stock worth $375,179,000 after buying an additional 68,579 shares during the period. Nordea Investment Management AB increased its position in shares of MetLife by 16.8% in the fourth quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock worth $347,735,000 after acquiring an additional 608,224 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of MetLife by 0.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,913,408 shares of the financial services provider’s stock valued at $320,430,000 after acquiring an additional 30,187 shares during the period. Finally, Swedbank AB lifted its holdings in shares of MetLife by 76.0% during the 4th quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider’s stock valued at $283,862,000 after acquiring an additional 1,496,645 shares in the last quarter. 94.99% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several brokerages recently issued reports on MET. StockNews.com downgraded MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Barclays lowered their target price on MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a research note on Friday, February 7th. Wells Fargo & Company boosted their price target on MetLife from $92.00 to $97.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 19th. Morgan Stanley increased their price objective on shares of MetLife from $101.00 to $109.00 and gave the company an “overweight” rating in a research report on Friday, February 28th. Finally, TD Cowen boosted their target price on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research report on Wednesday, November 27th. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $94.58.
MetLife Stock Performance
MET stock opened at $77.69 on Friday. The firm has a market cap of $52.92 billion, a P/E ratio of 13.01, a P/E/G ratio of 0.65 and a beta of 1.04. The stock’s 50 day simple moving average is $83.48 and its 200 day simple moving average is $82.36. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. MetLife, Inc. has a 12-month low of $67.30 and a 12-month high of $89.05.
MetLife (NYSE:MET – Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. As a group, equities research analysts predict that MetLife, Inc. will post 9.65 EPS for the current year.
MetLife Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th were issued a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a dividend yield of 2.81%. The ex-dividend date of this dividend was Tuesday, February 4th. MetLife’s dividend payout ratio (DPR) is presently 36.52%.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- What is the MACD Indicator and How to Use it in Your Trading
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Why is the Ex-Dividend Date Significant to Investors?
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- Basic Materials Stocks Investing
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).